Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | FTXHFirst Trust Nasdaq Pharmaceuticals ETF | VTIVanguard Morningstar Total Stock Market ETF |
|---|---|---|
| Market | USNasdaq | USNYSE Arca |
| Issuer | First Trust | Vanguard |
| Asset class | Equity · US | Equity · US |
| Expense ratio | 0.60%Expense ratio, filed 29 Jul 2025 | 0.03%Expense ratio, filed 28 Apr 2026 |
| Net assets | $36.2MAs of 30 Jun 2026 | $2.3TAs of 30 Jun 2026 |
| Holdings | 51As of 30 Jun 2026 | 3,546As of 30 Jun 2026 |
| 12-month distribution yield | 0.68% | 1.05% |
| Distributions | Quarterly$0.2890 in 12 months | Quarterly$3.9490 in 12 months |
| Last price | $42.7120 Oct 2026, 15:11 UTC | $377.0920 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | FTXH | VTI |
|---|---|---|
| FTXH | Same fund | 5.1%at least |
| VTI | 5.1%at least | Same fund |
FTXH and VTI
- Weighted overlap
- 5.1%
- Holdings in common
- 50
- FTXH holdings also in VTI
- 100.0% by count
- VTI holdings also in FTXH
- 2.5% by count
| Holding | Weight in FTXH | Weight in VTI | Overlap | Matched by |
|---|---|---|---|---|
| ELI LILLY & COMPANYELI LILLY & COMPANY COM US5324571083 | 7.77% | 1.40% | 1.40% | ISIN |
| JOHNSON & JOHNSONJOHNSON & JOHNSON COM US4781601046 | 6.96% | 0.84% | 0.84% | ISIN |
| ABBVIE INCABBVIE INC COM US00287Y1091 | 7.39% | 0.61% | 0.61% | ISIN |
| MERCK & COMPANY INCMERCK & COMPANY INC COM US58933Y1055 | 7.07% | 0.44% | 0.44% | ISIN |
| AMGEN INCAMGEN INC COM US0311621009 | 3.18% | 0.27% | 0.27% | ISIN |
| GILEAD SCIENCES INCGILEAD SCIENCES INC COM US3755581036 | 2.89% | 0.22% | 0.22% | ISIN |
| PFIZER INCPFIZER INC COM US7170811035 | 2.97% | 0.19% | 0.19% | ISIN |
| VERTEX PHARMACEUTICALS INCVERTEX PHARMACEUTICALS INC COM US92532F1003 | 3.41% | 0.17% | 0.17% | ISIN |
| BRISTOL-MYERS SQUIBB COMPANYBRISTOL-MYERS SQUIBB COMPANY COM US1101221083 | 6.29% | 0.16% | 0.16% | ISIN |
| REGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INC COM US75886F1075 | 2.72% | 0.09% | 0.09% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | FTXH | VTI |
|---|---|---|
| US dollar (USD) | 100.0% | 100.5% |